These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 2992862)

  • 1. False-positive technetium-99m DMSA renal imaging in two cases of malrotated kidney.
    Ueno K; Rikimaru S; Miyagi T; Mohri S
    Clin Nucl Med; 1985 Jul; 10(7):504-6. PubMed ID: 2992862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
    Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
    Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantification of separate renal function using Tc 99m DTPA and Tc 99m DMSA. Correlations between individual isotopic data and creatinine clearance].
    Chevet D; Moisan A; Le Pogamp P; Le Cloirec J; Wehbe B; Herry JY
    Nephrologie; 1984; 5(1):21-5. PubMed ID: 6328339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Tc-99m DMSA and Tc-99m DTPA in reflux.
    Gordon I
    Semin Urol; 1986 May; 4(2):99-107. PubMed ID: 3012742
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital renal anomaly: evaluation with 99mTc-dimercaptosuccinic acid renal scintigraphy.
    Hosokawa S; Kawamura J; Tomoyoshi T; Yoshida O
    Am J Kidney Dis; 1983 May; 2(6):655-9. PubMed ID: 6303118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of residual renal function and prediction of the prognosis of polycystic kidney disease by 99m Tc-dimercaptosuccinic acid (DMSA) renal scintigraphy.
    Kawamura J; Yoshida O
    Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):1031-4. PubMed ID: 6275152
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): in vitro correlation.
    Daly MJ; Jones W; Rudd TG; Tremann J
    J Nucl Med; 1979 Jan; 20(1):63-6. PubMed ID: 219166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioisotopic quantification of kidney function using Tc-99m-DMSA. Comparison with creatinine clearance in children with a single kidney].
    Baillet G; Gagnadoux MF; Mathonnat F; de Vernejoul P; Broyer M
    Nephrologie; 1986; 7(4):143-5. PubMed ID: 3025756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scintigraphy with technetium dimercaptosuccinic acid (99 m TC DMSA). Contribution to the functional assessment of individual kidneys (author's transl)].
    Abbou CC; Moretti JL; Chopin D; Sanabria E; Msallag M; Nebout T; Auvert J
    Nouv Presse Med; 1981 Apr; 10(18):1475-8. PubMed ID: 6265862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
    Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
    Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in children. Increased efficacy of technetium Tc 99m succimer in screening for renal disease.
    Rosen PR; Treves S; Ingelfinger J
    Am J Dis Child; 1985 Feb; 139(2):173-7. PubMed ID: 2983528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate.
    Lyons KP; Milne N; Karlsberg RP; Olson HG; Kuperus J
    Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential renal uptake of technetium-99m-DMSA and technetium-99m-DTPA.
    De Geeter F; Saelens E; Van Steelandt H; Degomme P
    J Nucl Med; 1993 Jul; 34(7):1217-8. PubMed ID: 8391071
    [No Abstract]   [Full Text] [Related]  

  • 14. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
    Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
    Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation of relative glomerular filtration rate and correlation with delayed technetium-99m DMSA imaging.
    Taylor A; Kipper M; Witztum K
    Clin Nucl Med; 1986 Jan; 11(1):28-31. PubMed ID: 3002699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal scintigraphy with technetium Tc 99m succimer: clinical utility in newborns with cystic renal dysplasia.
    Copely DJ; Smith R; Murakami ME
    South Med J; 1988 Jan; 81(1):99-100. PubMed ID: 2827323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhancement of the information value of kidney scintigraphy using 99m Tc-DMSA].
    Efimov ON; Volodin VM; Ivanov IuN
    Med Radiol (Mosk); 1988 Jun; 33(6):27-31. PubMed ID: 2838716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor technetium-99m-DMSA renal uptake with near normal technetium-99m-DTPA uptake caused by tubulointerstitial renal disease.
    Quinn RJ; Elder GJ
    J Nucl Med; 1991 Dec; 32(12):2273-4. PubMed ID: 1660540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pyelonephritis-induced parenchymal defects in children diagnosed by Tc 99m DMSA renal scintigraphy and intravenous urography].
    Biskjaer N; Thelle T
    Ugeskr Laeger; 1983 May; 145(21):1604-7. PubMed ID: 6308868
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
    Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
    Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.